This compound is an active pharmaceutical ingredient with a salt-like structure, composed of a chiral azabicyclo-octane derivative and a phenyl-dihydroisoquinoline carboxylate moiety, combined with succinic acid. It is primarily used as a pharmaceutical raw material in research and manufacturing settings.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing this compound?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
Ethyl eicosapentaenoate
pharmaceutical raw material
Vaprisol
pharmaceutical raw material
Menatetrenone
pharmaceutical raw material
Azilsartan medoxomil
pharmaceutical raw material
(1S,3R,4S)-quinuclidin-3-yl (S)-1-(phenyl-d5)-3,4-dihydroisoquinoline-2(1H)-carboxylate
pharmaceutical raw material
(1S,3S)-Solifenacin Hydrochloride
pharmaceutical raw material
Solifenacin
pharmaceutical raw material
Solifenacin succinate
pharmaceutical raw material
[(3R)-1-azabicyclo[2.2.2]octan-3-yl] (1R)-1-phenyl-3,4-dihydro-1H-isoquinoline-2-carboxylate;butanedioic acid
RXZMMZZRUPYENV-UMIAIAFLSA-N
C1CN2CCC1[C@H](C2)OC(=O)N3CCC4=CC=CC=C4[C@H]3C5=CC=CC=C5.C(CC(=O)O)C(=O)O
Sourcing this compound?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.